Summary & Overview
CPT 45378: Diagnostic Colonoscopy with Specimen Collection
CPT code 45378 is a foundational billing code for diagnostic colonoscopy procedures, a key service in the early detection and management of colorectal diseases. This code covers the use of a flexible endoscope to examine the colon and rectum, including the collection of specimens by brushing or washing when indicated. Colonoscopy is widely recognized as an essential procedure for screening, diagnosis, and surveillance of conditions such as colon polyps, colorectal cancer, and other gastrointestinal abnormalities.
Major national payers, including Aetna, Blue Cross Blue Shield, Cigna Health, Medicare, and UnitedHealthcare, provide coverage for this procedure, reflecting its importance in preventive and diagnostic care. The publication offers a comprehensive overview of clinical indications, typical sites of service, and related billing practices. Readers will gain insights into current policy updates, coding benchmarks, and the clinical context surrounding the use of 45378.
The article also highlights common modifiers, associated provider taxonomies, and relevant ICD-10 diagnoses, equipping stakeholders with the information needed to understand the scope and nuances of billing for diagnostic colonoscopy. Additionally, related CPT codes are discussed to clarify distinctions between diagnostic and therapeutic colonoscopy services. This summary serves as a resource for healthcare professionals, administrators, and policy analysts seeking clarity on national standards and payer coverage for colonoscopy procedures.
CPT Code Overview
CPT code 45378 represents a diagnostic colonoscopy using a flexible endoscope, including the collection of specimen(s) by brushing or washing when performed. This procedure is classified under Endoscopy Procedures on the Colon and Rectum and is typically performed in an outpatient hospital setting (Place of Service 22). Colonoscopy is a critical tool for the detection and evaluation of various colon and rectal conditions, providing direct visualization and the ability to collect samples for further analysis.
Clinical & Coding Specifications
Clinical Context
A 55-year-old patient presents to the outpatient hospital setting for evaluation of rectal bleeding and changes in bowel habits. The gastroenterology physician performs a diagnostic colonoscopy using a flexible endoscope. During the procedure, the physician inspects the entire colon and may collect specimens by brushing or washing if abnormal areas are identified. The procedure is performed to investigate symptoms and rule out conditions such as colon polyps, colorectal cancer, or other colonic abnormalities. The clinical workflow includes pre-procedure assessment, informed consent, colonoscopy with specimen collection as indicated, and post-procedure monitoring.
Coding Specifications
-
Modifiers:
- Modifier
26: Professional Component – Used when only the physician's professional services are billed, not the facility or equipment. - Modifier
33: Preventive Services – Applied when the colonoscopy is performed for preventive screening, such as for colorectal cancer. - Modifier
52: Reduced Services – Used if the procedure is partially completed or not all aspects are performed. - Modifier
53: Discontinued Procedure – Used if the procedure is started but discontinued due to patient safety or other reasons.
- Modifier
-
Provider Taxonomies:
Taxonomy Code Specialty Name 207RG0100XGastroenterology Physician 207Q00000XFamily Medicine Physician 207R00000XInternal Medicine Physician
These taxonomies represent the specialties commonly performing or supervising colonoscopy procedures.
Related Diagnoses
-
K63.5: Polyp of colon- Indicates the presence of a colon polyp, which may be detected during colonoscopy and is a common reason for the procedure.
-
Z12.11: Encounter for screening for malignant neoplasm of colon- Used when the colonoscopy is performed as a screening test for colorectal cancer, often in asymptomatic patients.
-
R19.5: Other fecal abnormalities- Applied when the patient presents with abnormal stool findings, prompting diagnostic colonoscopy.
-
K52.9: Noninfective gastroenteritis and colitis, unspecified- Used when the patient has symptoms of colitis or gastroenteritis without a specific infectious cause, warranting colonoscopic evaluation.
-
D12.6: Benign neoplasm of colon, unspecified- Indicates a benign tumor in the colon, which may be found or evaluated during colonoscopy.
Related CPT Codes
-
45379: Colonoscopy, flexible; with removal of foreign body- Used when a foreign body is identified and removed during colonoscopy. May be performed in conjunction with diagnostic colonoscopy if a foreign body is found.
-
45380: Colonoscopy, flexible; with biopsy, single or multiple- Used when tissue biopsies are taken during colonoscopy. Often performed if abnormal mucosa or lesions are seen.
-
45381: Colonoscopy, flexible; with directed submucosal injection(s), any substance- Used when submucosal injections (e.g., saline, medication) are administered during colonoscopy, typically to aid in polyp removal or mark lesions.
-
45382: Colonoscopy, flexible; with control of bleeding, any method- Used when active bleeding is encountered and controlled during colonoscopy, such as with cautery or clips.
-
45384: Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) by hot biopsy forceps or bipolar cautery- Used when polyps or lesions are removed using hot biopsy forceps or cautery. May be an alternative or additional procedure to diagnostic colonoscopy if such findings are present.
These codes are related to 45378 and may be used together or as alternatives depending on findings and interventions during the colonoscopy.
National Reimbursement Benchmarks
For CPT code 45378, national mean rates show that UnitedHealth Group has the highest average reimbursement at $517.90, while Medicare's mean rate is $293.76. The average commercial mean rate, represented by BUCA, is $363.63, which is notably higher than Medicare but lower than UnitedHealth Group and Cigna.
Rate dispersion, measured by the difference between the 75th and 25th percentiles, varies significantly across payers. Aetna has the tightest range at $113.40, indicating less variability in rates, while UnitedHealth Group exhibits the widest range at $279.33, reflecting greater variability in commercial reimbursement. Cigna and Blue Cross Blue Shield also show substantial dispersion, with ranges of $206.50 and $181.59, respectively.
The table and chart below present a detailed breakdown of national benchmarks for each payer, including mean rates and percentile values.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.